门冬氨酸鸟氨酸针持续微量泵给药对肝性脑病患者肝功能及血氨水平的影响

黄献球

黄献球. 门冬氨酸鸟氨酸针持续微量泵给药对肝性脑病患者肝功能及血氨水平的影响[J]. 实用临床医药杂志, 2013, (7): 110-111,113. DOI: 10.7619/jcmp.201307039
引用本文: 黄献球. 门冬氨酸鸟氨酸针持续微量泵给药对肝性脑病患者肝功能及血氨水平的影响[J]. 实用临床医药杂志, 2013, (7): 110-111,113. DOI: 10.7619/jcmp.201307039
HUANG Xianqiu. Effects of sustained micro-pump injection of ornithine aspartate needle on liver function and blood ammonia for patients with hepatic encephalopathy[J]. Journal of Clinical Medicine in Practice, 2013, (7): 110-111,113. DOI: 10.7619/jcmp.201307039
Citation: HUANG Xianqiu. Effects of sustained micro-pump injection of ornithine aspartate needle on liver function and blood ammonia for patients with hepatic encephalopathy[J]. Journal of Clinical Medicine in Practice, 2013, (7): 110-111,113. DOI: 10.7619/jcmp.201307039

门冬氨酸鸟氨酸针持续微量泵给药对肝性脑病患者肝功能及血氨水平的影响

基金项目: 广西贺州市科技攻关与新产品试制项目,中国高校医学期刊临床专项资金
详细信息
  • 中图分类号: R742

Effects of sustained micro-pump injection of ornithine aspartate needle on liver function and blood ammonia for patients with hepatic encephalopathy

  • 摘要: 目的 探讨门冬氨酸鸟氨酸针持续微量泵注入治疗肝性脑病的临床疗效.方法 将71例肝性脑病患者随机分为治疗组(n=36)和对照组(n=36),治疗组应用门冬氨酸鸟氨酸针微量泵注入,对照组应用门冬氨酸鸟氨酸针静脉滴注.观察2组患者神志恢复正常时间及治疗前后肝功能、血氨值变化情况.结果 治疗组患者苏醒时间为(11.2±2.1)h,对照组苏醒时间为(18.5±2.3)h,治疗组患者苏醒时间明显短于对照组.2组治疗后血氨、丙氨酸氨基转移酶(ALT)、总胆红素(TBIL)均较治疗前明显降低;治疗组治疗后血氨、ALT、TBIL水平明显低于对照组治疗后.结论 应用门冬氨酸鸟氨酸针持续微量泵注入比单纯静脉滴注疗效更佳,值得临床推广应用.
  • Pipili C, Polydorou A, Pantelias K. Improvement of hepatic encephalopathy by application of peritoneal dialysis in a patient with non-end-stage renal disease [J]. Peritoneal Dialysis International, 2013(2):213.
    Sharma P, Sharma B C. Disaccharides in the treatment of hepatic encephalopathy [J]. Metabolic Brain Disease, 2013.
    Kalaitzakis E, Josefsson A, Castedal M. Hepatic encephalopathy is related to anemia and fat-free mass depletion in liver transplant candidates with cirrhosis [J]. Scandinavian Journal of Gastroenterology, 2013.
    Hung T H, Lay C J, Chang C M. The effect of infections on the mortality of cirrhotic patients with hepatic encephalopathy [J]. Epidemiology and Infection, 2013.
    陈灏珠. 实用内科学 [M]. 北京:人民卫生出版社, 2001.1884.
    Safonova M V, Kozlova I V, Ovsiarnikova V V. Hepatic encephalopathy and colon pathology in liver cirrhosis [J]. Eksp Klin Gastroenterol, 2012(6):20.
    Patidar K R, Bajaj J S. Antibiotics for the treatment of hepatic encephalopathy [J]. Metabolic Brain Disease, 2013.
    Cudalbu C. In vivo studies of brain metabolism in animal models of Hepatic Encephalopathy using (1)H Magnetic ResonanceSpectroscopy [J]. Metabolic Brain Disease, 2012.
    Tranah T H, Vijay G K, RyanJ M. Systemic inflammation and ammonia in hepatic encephalopathy [J]. Metabolic Brain Disease, 2013(1):1.
    Haussinger D. Hepatic encephalopathy [J]. Acta Gastroenterologica Belgica, 2010(4):457.
    贲立军, 徐萍. 门冬氨酸鸟氨酸与纳洛酮联用治疗肝性脑病的疗效观察 [J]. 宁夏医学杂志, 2011(2):157.doi: 10.3969/j.issn.1001-5949.2011.02.028.
    孙芳. 门冬氨酸鸟氨酸治疗肝性脑病50例疗效观察 [J]. 中国现代药物应用, 2011(5):103.doi: 10.3969/j.issn.1673-9523.2011.05.091.
    袁翠云, 张长青. 门冬氨酸鸟氨酸治疗肝性脑病的临床观察 [J]. 白求恩军医学院学报, 2011(5):346.doi: 10.3969/j.issn.1672-2876.2011.05.018.
计量
  • 文章访问数:  162
  • HTML全文浏览量:  48
  • PDF下载量:  14
  • 被引次数: 0
出版历程
  • 发布日期:  2013-06-12

目录

    /

    返回文章
    返回
    x 关闭 永久关闭